NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo announces the CE marking & European launch of the single-patient-use rainbow® SuperSensor™, with 12 noninvasive parameters on a single sensor.
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Morgan Stanley 19th Annual Global Healthcare Conference on Thursday, Septe
Masimo's (MASI) ORi is expected to provide early warnings of impending hypoxemia during the ETI procedure, thus aiding in averting any adverse incident.
Masimo (MASI) partners with Penington Institute to increase awareness on overdose from prescription opioids.
NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study found that use of Masimo ORi™ on ICU patients may facilitate "preventive action" against hypoxemia during endotracheal intubation.
The stock price of Masimo Corporation, a medical devices company best known for its remote patient monitoring systems, reached its all-time high of $287 just last week before a recent decline resulted
Masimo's (MASI) western Europe launch of SafetyNet Alert not only expands its global presence but also aids in protecting patients taking opioids at home.
LONDON--(BUSINESS WIRE)--Masimo is marking International Overdose Awareness Day by partnering with the Penington Institute to raise awareness of the risks of opioid overdose.
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo SafetyNet Alert™, an oxygen saturation monitoring and alert system designed for use at home, has been launched in Western Europe.
Investors continue to be optimistic about Masimo (MASI) owing to its slew of product launches and regulatory approvals.
Masimo (MASI) reports study findings that will aid clinicians in getting meaningful information with respect to monitoring the volume status in critically ill patients with spontaneous breathing.
NEUCHATEL, Switzerland--(BUSINESS WIRE)--A study found a "strong correlation" between change in Masimo PVi® & volume of fluid removed during hemodialysis in spontaneously breathing patients.
Masimo's (MASI) Bridge device is likely to allow more patients to be benefited by auriculotherapy, thereby reducing the possibility of opioid overuse.
Masimo's (MASI) robust product shipments, along with strong rebound in sensor sales, drive its Q2 sales.
Masimo Corporation (MASI) CEO Joe Kiani on Q2 2021 Results - Earnings Call Transcript
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE